At the peak of the COVID-19 pandemic, many vaccine skeptics turned to ivermectin, a medication proven to fight off parasitic ...

Rejoice, fellow vaccine enthusiasts-it looks like there's good news on the horizon for Novavax, everyone's favorite scrappy, ...

Those of us who paid attention to their COVID wishcasting are not the least bit surprised that measles is killing and ...

STAT is tracking, day by day, what's happened in the words of science and health during the first months of the Trump ...

The Novavax COVID-19 vaccine is set to finally receive full approval from the FDA. The agency said Novavax must collect more ...

The new FDA chief reiterated his commitment to speeding up drug approval processes and run the agency by “gold standard ...

Over the next four months, the Vaccine Integrity Project will hold information-gathering sessions with medical associations, ...

Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug ...

Whooping cough cases are rising, and doctors are bracing for yet another tough year. There have been 8,485 cases reported in ...

Some key public health figures are taking an extraordinary step to try to shore up U.S. vaccination policy, feared to be ...

Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the ...

The allowed claims in this patent encompass a novel dosing regimen of 200 ppm to 320 ppm gNO for 10 to 45 minutes, 2 to 5 times per day, to provide a nitric oxide-load (NO load) of 300 ppm-hrs to 900 ...